I added to $AEHR today as well. Here's my thesis why: The growth inflection: FY2027 revenue guided to $130–150M vs. FY2026's $50M — 160–200% growth Guidance carries an 18–22% pre-tax margin, so this is profitable growth, not revenue bought with margin Demand is contracted, not hoped for: Record Q4 bookings of $60.7M, up ~500% YoY Effective backlog of $100.6M — covering ~72% of the FY27 guidance midpoint The end-market pivot is the real story ~95% of revenue now from AI processors, silicon photonics and power semis — versus 95% EV silicon carbide two years ago AI expected to be ~70% of FY2027 revenue, silicon photonics ~15% Valuation is the main pushback: ~21x guided FY27 sales at recent prices, and one bear case puts it at 59x forward FY2028 profit. I expect lumpy prints, not a smooth ramp but firmly believe this will be a large company in 2028! NFA. DYOR